Real-world effectiveness and safety of guselkumab in adult patients with facial and/or genital psoriasis: a 52-week analysis from the Italian multicentric GULLIVER study

This Italian real-world study demonstrated the high effectiveness and a good safety profile of guselkumab in treating facial and genital psoriasis.

Authors

Institutions

Publication Details

Journal
Journal of Dermatological Treatment
Published
2026-02-05
DOI
https://doi.org/10.1080/09546634.2025.2600241
Primary Topic
Psoriasis: Treatment and Pathogenesis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real-world effectiveness and safety of guselkumab in adult patients with facial and/or genital psoriasis: a 52-week analysis from the Italian multicentric GULLIVER study

Luca Stingeni, C. Bonifati, Claudia Lasagni, Massimo Donini et al.
Journal of Dermatological Treatment
Psoriasis: Treatment and Pathogenesis
article

Real-world effectiveness and safety of guselkumab in adult patients with facial and/or genital psoriasis: a 52-week analysis from the Italian multicentric GULLIVER study

Luca Stingeni, C. Bonifati, Claudia Lasagni, Massimo Donini, S. Lembo, Martina Burlando, Talia Gramiccia, Concetta Potenza, Giuseppe Stinco, A. Offidani, Franco Rongioletti, L. Atzori, Paola Savoia, Sabatino Pallotta, Claudio Guarneri, Stefano Piaserico, Giuseppe Micali, Marco ROMANELLI, Vito Giuseppe Di Lernia, G. Argenziano, Federico Bardazzi, Manuela Papini, Antonio Giovanni Richetta, Marco Galluzzo, Leonardo Zichichi, Francesca Satolli, Carlo Giovanni Carrera, Maria Concetta Fargnoli, Ketty Peris, Federico Saibene, Maria Rita Bongiorno, Francesco Loconsole, Claudia Giofrè, Paolo Dapavo, Antonio Costanzo, Francesca Prignano
article en

Abstract

This Italian real-world study demonstrated the high effectiveness and a good safety profile of guselkumab in treating facial and genital psoriasis.

Journal of Dermatological TreatmentVol. 37(1)
Università Cattolica del Sacro Cuore (IT), University of Pisa (IT), University of Messina (IT), University of Rome Tor Vergata (IT), Marche Polytechnic University (IT), Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT), University of Parma (IT), University of Udine (IT), University of Salerno (IT), Humanitas University (IT), University of Padua (IT), Vita-Salute San Raffaele University (IT), University of Cagliari (IT), University of Ferrara (IT), University of L'Aquila (IT), University of Perugia (IT), Luigi Einaudi Foundation (IT), Agostino Gemelli University Polyclinic (IT), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), San Antonio Regional Hospital (US), University of Catania (IT), Université Ouaga II (BF), Azienda Usl 8 Arezzo (IT), Azienda Ospedaliero-Universitaria di Modena (IT), University Hospitals Parma Medical Center (US), Federico II University Hospital (IT), Azienda USL di Bologna (IT), University of Campania "Luigi Vanvitelli" (IT), Institute of Dermatology (TH), Johnson & Johnson (Israel) (IL), University Dermatology (US), Policlinico Tor Vergata (IT), University of Palermo (AR), San Gallicano Hospital (IT), Ospedale Policlinico San Martino (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), IRCCS Humanitas Research Hospital (IT), University of Florence (IT), University of Bari Aldo Moro (IT), Sapienza University of Rome (IT)
Openalex Percentile: Top 64%
Psoriasis: Treatment and Pathogenesis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.